午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Nicardipine EP Impurity A
Nicardipine EP Impurity A
  • Nicardipine EP Impurity A
  • Nicardipine EP Impurity A
  • Nicardipine EP Impurity A
  • Nicardipine EP Impurity A
  • Nicardipine EP Impurity A

Nicardipine EP Impurity A NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-07-31

Product Details

Product Name: Nicardipine EP Impurity A CAS No.: 59875-58-0
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/07/31
Molecular formula: C26H27N3O6

Nicardipine EP Impurity A;59875-58-0

Article illustration

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com


  • Product Information

  • Product Number: N020013

  • English Name: Nicardipine EP Impurity A

  • English Alias: 3-(2-(benzyl(methyl)amino)ethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate

  • CAS Number: 59875-58-0

  • Molecular Formula: C??H??N?O?

  • Molecular Weight: 477.51

  • As a European Pharmacopoeia (EP) standard impurity of nicardipine, the research advantages of this compound include:

  • Serving as an EP-compliant reference standard for direct use in quality testing of nicardipine APIs and formulations, ensuring consistency with international pharmacopoeia requirements;

  • Helping to analyze the by-product formation mechanism of amino substitution reactions in nicardipine synthesis to optimize processes and reduce the formation of benzylmethylamine impurities;

  • Assisting in evaluating the impact of nitro and amino structures on drug stability and safety to provide a basis for establishing storage conditions and quality standards.

  • Applications

  • Quality Control: Used as an EP standard impurity reference for system suitability tests in HPLC and other detection methods to verify whether the content of this impurity in nicardipine meets EP limits;

  • Drug Development: In generic drug research, used to compare the impurity profile of the original drug to ensure quality consistency between the generic and original drug;

  • Process Optimization: Guiding the optimization of amination and pyridine ring condensation reaction conditions in the synthesis route to reduce the generation of this impurity through impurity content analysis.

  • Background Description

  • Nicardipine is a commonly used dihydropyridine calcium channel blocker in clinical practice for the treatment of hypertension and angina. If amino substitution reactions or pyridine ring construction are not properly controlled during its synthesis, impurities containing benzylmethylamine structures (such as Impurity A) are easily generated. The European Pharmacopoeia (EP) has clear limits for this impurity, making research on it a necessary part of international quality control for nicardipine.
  • Research Status

  • Current research focuses on:

  • Detection Method Optimization: Using EP-recommended HPLC-UV methods or LC-MS combined techniques to improve the detection sensitivity and specificity of this impurity;

  • Synthesis Process Improvement: Reducing the generation of benzylmethylamine derivatives by adjusting the reagent ratio and temperature of amination reactions;

  • Stability Studies: Investigating the degradation behavior of this impurity under light, high temperature, and high humidity conditions to evaluate its impact on nicardipine formulation stability;

  • Toxicological Evaluation: Studying the potential genotoxicity of nitro and amino structures through in vitro cell experiments to provide data support for establishing safe limits.

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com




Company Profile Introduction

1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability. 2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs. 3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects. 4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes. 5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/5mg
VIP1Y
Guangzhou Tosun Pharmaceutical Ltd
2025-01-24
$0.00/10mg
VIP8Y
Guangzhou PI PI BIOTECH INC
2022-04-19
$0.00/10mg
VIP8Y
Guangzhou PI PI BIOTECH INC
2021-09-20
INQUIRY